𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-p53 antibodies in patients with dermatomyositis/polymyositis

✍ Scribed by Yoshihiro Mimura; Norihito Yazawa; Zenshirou Tamaki; Ryuichi Ashida; Masatoshi Jinnin; Yoshihide Asano; Yayoi Tada; Masahide Kubo; Hironobu Ihn; Kunihiko Tamaki


Publisher
Springer
Year
2006
Tongue
English
Weight
100 KB
Volume
26
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A subluxing arthropathy associated with
✍ Chester V. Oddis; Thomas A. Medsger Jr; Lawrence A. Cooperstein πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 505 KB

Of 180 patients with polymyositis/dermatomyositis (PM/DM) seen at the University of Pittsburgh and affiliated hospitals since 1975, 21 of 100 tested positive for the anti-Jo-1 antibody. Sixteen of the 21 patients were women and 18 were white. Fifteen had adult PM, 4 had myositis in overlap with scle

Frequency of relapses in patients with p
✍ Beverley A. Phillips; Paul Zilko; Michael J. Garlepp; Frank L. Mastaglia πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 114 KB πŸ‘ 1 views

The frequency of clinical and biochemical relapses was determined in a group of 50 patients with polymyositis (PM), dermatomyositis (DM), or overlap syndromes who were followed for periods of up to 13 years. Relapses occurred in 30 of the 50 patients (60%) during the period of followup. The annual r

Adult respiratory distress syndrome in p
✍ Kevin Clawson; Chester V. Oddis πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 483 KB

We report 3 patients with polymyositis and the anti-Jo-1 antibody who developed fatal adult respiratory distress syndrome (ARDS). Other than the presence of the anti-Jo-1 antibody, there were no other consistent clinical features at the onset of disease that were predictive of ARDS development.